Sponsor Information
JANSSEN-CILAG PTY LTD
Active Ingredients
Ustekinumab
462464
SETRELVO ustekinumab 90 mg/ 1 mL solution for injection pre-filled pen (One-Press patient-controlled injector)
Janssen-Cilag Pty Ltd
October 18, 2024
Medicine
Medicine
Registered
JANSSEN-CILAG PTY LTD
Ustekinumab